BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol 2016; 22(20): 4794-4801 [PMID: 27239106 DOI: 10.3748/wjg.v22.i20.4794] [Cited by in CrossRef: 183] [Cited by in F6Publishing: 151] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Loo SY, Vutcovici M, Bitton A, Lakatos PL, Azoulay L, Suissa S, Brassard P. Risk of Malignant Cancers in Inflammatory Bowel Disease. J Crohns Colitis 2019;13:1302-10. [PMID: 30874294 DOI: 10.1093/ecco-jcc/jjz058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
2 You W, Xu Z, Di A, Liu P, Pang C, Wang J, Li X, Wang Y, Yu B, Liu X, Zhao G. Mechanism by Which Tong Xie Yao Fang Heals the Intestinal Mucosa of Rats with Ulcerative Colitis through the Hippo Pathway. Evid Based Complement Alternat Med 2021;2021:5533914. [PMID: 34504536 DOI: 10.1155/2021/5533914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao X, Lv C, Chen S, Zhi F. A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells. Cell Biol Int 2018;42:1097-105. [PMID: 28921811 DOI: 10.1002/cbin.10875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ye C, Zhu S, Yuan J. Construction of ceRNA Network to Reveal Potential Biomarkers in Crohn's Disease and Validation in a TNBS Induced Mice Model. J Inflamm Res 2021;14:6447-59. [PMID: 34880646 DOI: 10.2147/JIR.S338053] [Reference Citation Analysis]
5 Kim H, Venancio VP, Fang C, Dupont AW, Talcott ST, Mertens-Talcott SU. Mango (Mangifera indica L.) polyphenols reduce IL-8, GRO, and GM-SCF plasma levels and increase Lactobacillus species in a pilot study in patients with inflammatory bowel disease. Nutr Res 2020;75:85-94. [PMID: 32109839 DOI: 10.1016/j.nutres.2020.01.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
6 Kavanagh RG, O'Grady J, Carey BW, McLaughlin PD, O'Neill SB, Maher MM, O'Connor OJ. Low-Dose Computed Tomography for the Optimization of Radiation Dose Exposure in Patients with Crohn's Disease. Gastroenterol Res Pract 2018;2018:1768716. [PMID: 30515203 DOI: 10.1155/2018/1768716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Pastille E, Frede A, McSorley HJ, Gräb J, Adamczyk A, Kollenda S, Hansen W, Epple M, Buer J, Maizels RM, Klopfleisch R, Westendorf AM. Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog 2017;13:e1006649. [PMID: 28938014 DOI: 10.1371/journal.ppat.1006649] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
8 Jeng LB, Kumar Velmurugan B, Chen MC, Hsu HH, Ho TJ, Day CH, Lin YM, Padma VV, Tu CC, Huang CY. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. J Cell Physiol 2018;233:7134-42. [PMID: 29574877 DOI: 10.1002/jcp.26532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
9 Zhang X, Ma L, Zhang C, Hou B, Zhou Y, Yu S. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterol Hepatol 2020:S0210-5705(20)30405-2. [PMID: 33317921 DOI: 10.1016/j.gastrohep.2020.10.008] [Reference Citation Analysis]
10 Fujita M, Matsubara N, Matsuda I, Maejima K, Oosawa A, Yamano T, Fujimoto A, Furuta M, Nakano K, Oku-Sasaki A, Tanaka H, Shiraishi Y, Mateos RN, Nakai K, Miyano S, Tomita N, Hirota S, Ikeuchi H, Nakagawa H. Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. Oncotarget 2018;9:969-81. [PMID: 29416670 DOI: 10.18632/oncotarget.22867] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kotredes KP, Thomas B, Gamero AM. The Protective Role of Type I Interferons in the Gastrointestinal Tract. Front Immunol 2017;8:410. [PMID: 28428788 DOI: 10.3389/fimmu.2017.00410] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
12 Kuriakose Kuzhiyanjal AJ, Nigam GB, Afzal M. Amelanotic anorectal malignant melanoma in an ulcerative colitis patient: a rare coincidence or a rare association. BMJ Case Rep 2021;14:e240398. [PMID: 33727297 DOI: 10.1136/bcr-2020-240398] [Reference Citation Analysis]
13 Daugherty TT, Swerlick RA. Clinical context for cancer risk of immunosuppressive agents used in dermatology. Dermatol Ther 2021;34:e14433. [PMID: 33084077 DOI: 10.1111/dth.14433] [Reference Citation Analysis]
14 Direito R, Rocha J, Lima A, Gonçalves MM, Duarte MP, Mateus V, Sousa C, Fernandes A, Pinto R, Boavida Ferreira R, Sepodes B, Figueira ME. Reduction of Inflammation and Colon Injury by a Spearmint Phenolic Extract in Experimental Bowel Disease in Mice. Medicines (Basel) 2019;6:E65. [PMID: 31174376 DOI: 10.3390/medicines6020065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Baig A, Avlasevich SL, Torous DK, Bemis JC, Saubermann LJ, Lovell DP, MacGregor JT, Dertinger SD. Assessment of systemic genetic damage in pediatric inflammatory bowel disease. Environ Mol Mutagen 2020;61:901-9. [PMID: 32761646 DOI: 10.1002/em.22403] [Reference Citation Analysis]
16 Kushkevych I, Bychkov M, Bychkova S, Gajdács M, Merza R, Vítězová M. ATPase Activity of the Subcellular Fractions of Colorectal Cancer Samples under the Action of Nicotinic Acid Adenine Dinucleotide Phosphate. Biomedicines 2021;9:1805. [PMID: 34944620 DOI: 10.3390/biomedicines9121805] [Reference Citation Analysis]
17 Mendonça LABM, Dos Santos Ferreira R, de Cássia Avellaneda Guimarães R, de Castro AP, Franco OL, Matias R, Carvalho CME. The Complex Puzzle of Interactions Among Functional Food, Gut Microbiota, and Colorectal Cancer. Front Oncol 2018;8:325. [PMID: 30234008 DOI: 10.3389/fonc.2018.00325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
18 Chang M, Chang L, Chang HM, Chang F. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease. Clinical Colorectal Cancer 2018;17:e29-37. [DOI: 10.1016/j.clcc.2017.06.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
19 Klepp P, Brackmann S, Cvancarova M, Hoivik ML, Hovde Ø, Henriksen M, Huppertz-Hauss G, Bernklev T, Hoie O, Kempski-Monstad I, Solberg IC, Stray N, Jahnsen J, Vatn MH, Moum B. Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterol 2020;7:e000361. [PMID: 32337058 DOI: 10.1136/bmjgast-2019-000361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Abu-Sbeih H, Wang Y. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020;26:662-668. [PMID: 31560045 DOI: 10.1093/ibd/izz212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Kiu KT, Chen HL, Huang MT, Sung CW, Liaw YP, Chang CC, Wang YH, Chen HA. Outcome Analysis of Patients with Gallstone Disease Receiving Cholecystectomy: A Population-Based Cohort Study. Digestion 2017;95:132-9. [PMID: 28166522 DOI: 10.1159/000455072] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Kristo I, Riss S, Argeny S, Maschke S, Chitsabesan P, Stift A. Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease. World J Gastroenterol 2017; 23(3): 472-477 [PMID: 28210083 DOI: 10.3748/wjg.v23.i3.472] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
23 Wang G, Joel MDM, Yuan J, Wang J, Cai X, Ocansey DKW, Yan Y, Qian H, Zhang X, Xu W, Mao F. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology 2020;28:603-16. [PMID: 31938969 DOI: 10.1007/s10787-019-00683-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Foteinogiannopoulou K, Mala A, Koutroubakis IE. Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case Report. Inflamm Bowel Dis 2021;27:e55-6. [PMID: 33331639 DOI: 10.1093/ibd/izaa332] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Xu F, Dahlhamer JM, Terlizzi EP, Wheaton AG, Croft JB. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016. Dig Dis Sci 2019;64:1798-808. [DOI: 10.1007/s10620-019-05494-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Liu Y, Gusev A, Heng YJ, Alexandrov LB, Kraft P. Somatic mutational profiles and germline polygenic risk scores in human cancer. Genome Med 2022;14:14. [PMID: 35144655 DOI: 10.1186/s13073-022-01016-y] [Reference Citation Analysis]
28 Núñez F P, Quera R, Rubin DT. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc 2022; 14(2): 85-95 [DOI: 10.4253/wjge.v14.i2.85] [Reference Citation Analysis]
29 Yasunaga M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin Cancer Biol 2020;64:1-12. [PMID: 31181267 DOI: 10.1016/j.semcancer.2019.06.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
30 Ong SS, Walter SD, Chen X, Vora GK, Daluvoy M, Proia AD, Mruthyunjaya P. Ocular Surface Epithelial Atypia Mimicking Squamous Neoplasia in Association With Ulcerative Colitis. Cornea 2017;36:502-5. [DOI: 10.1097/ico.0000000000001144] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Fu Y, Yuan SS, Zhang LJ, Ji ZL, Quan XJ. Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis. Oncol Lett 2020;20:2595-605. [PMID: 32782577 DOI: 10.3892/ol.2020.11833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wan J, Wang X, Zhang Y, Chen M, Wang M, Wu K, Liang J. Systematic review and meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia. Aliment Pharmacol Ther 2022. [PMID: 35166389 DOI: 10.1111/apt.16789] [Reference Citation Analysis]
33 Ming SWY, Zhou Y, Smith M, Were J. A Retrospective Database Cohort Study Evaluating the Association Between Immune Suppressive Therapy and the Development of Cancer in Patients with Atopic Dermatitis Within UK Primary Care. EMJ. [DOI: 10.33590/emj/22-00004] [Reference Citation Analysis]
34 Pattison AM, Merlino DJ, Blomain ES, Waldman SA. Guanylyl cyclase C signaling axis and colon cancer prevention. World J Gastroenterol 2016; 22(36): 8070-8077 [PMID: 27688649 DOI: 10.3748/wjg.v22.i36.8070] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
35 Bai B, Wu F, Ying K, Xu Y, Shan L, Lv Y, Gao X, Xu D, Lu J, Xie B. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics 2021;11:6225-39. [PMID: 33995655 DOI: 10.7150/thno.55939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
36 Leman JKH, Munoz-Erazo L, Kemp RA. The Intestinal Tumour Microenvironment. Adv Exp Med Biol 2020;1226:1-22. [PMID: 32030672 DOI: 10.1007/978-3-030-36214-0_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Qin L, Yao ZQ, Chang Q, Zhao YL, Liu NN, Zhu XS, Liu QQ, Wang LF, Yang AG, Gao CF, Li JT. Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis. Oncotarget 2017;8:7391-404. [PMID: 28030847 DOI: 10.18632/oncotarget.14080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
38 Alkhayyat M, Abureesh M, Gill A, Khoudari G, Abou Saleh M, Mansoor E, Regueiro M. Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy. Inflamm Bowel Dis 2021;27:1052-60. [PMID: 33051651 DOI: 10.1093/ibd/izaa252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Zeng B, Shi S, Ashworth G, Dong C, Liu J, Xing F. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis 2019;10:315. [PMID: 30962426 DOI: 10.1038/s41419-019-1540-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 17.7] [Reference Citation Analysis]
40 Haddad A, Al-Sabbagh MQ, Al-Ani H, Siyam AM, Aborajooh E, Iwata T, Kimura S, Shariat SF, Abufaraj M. Inflammatory bowel disease and prostate cancer risk: A systematic review. Arab J Urol 2020;18:207-12. [PMID: 33312730 DOI: 10.1080/2090598X.2020.1761674] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Maryńczak K, Włodarczyk J, Sabatowska Z, Dziki A, Dziki Ł, Włodarczyk M. Colitis-Associated Colorectal Cancer in Patients with Inflammatory Bowel Diseases in a Tertiary Referral Center: A Propensity Score Matching Analysis. J Clin Med 2022;11:866. [PMID: 35160321 DOI: 10.3390/jcm11030866] [Reference Citation Analysis]
42 Weimers P, Ankersen DV, Munkholm P. Biomarkers for Remote Monitoring. In: Sheng Ding N, De Cruz P, editors. Biomarkers in Inflammatory Bowel Diseases. Cham: Springer International Publishing; 2019. pp. 271-8. [DOI: 10.1007/978-3-030-11446-6_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Chen X, Wang Y, Wang J, Wen J, Jia X, Wang X, Zhang H. Accumulation of T-helper 22 cells, interleukin-22 and myeloid-derived suppressor cells promotes gastric cancer progression in elderly patients. Oncol Lett 2018;16:253-61. [PMID: 29928409 DOI: 10.3892/ol.2018.8612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Kimmel J, Axelrad J. The Complex Interplay Between Inflammatory Bowel Disease and Malignancy. Curr Gastroenterol Rep 2020;22. [DOI: 10.1007/s11894-020-0747-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Lordan R, Tsoupras A, Zabetakis I. The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment. Adv Nutr 2019;10:148-64. [PMID: 30721934 DOI: 10.1093/advances/nmy090] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
46 Vuyyuru SK, Desai D, Kedia S, Dhoble P, Sahu P, Kante B, Agarwal S, Bopanna S, Dhingra R, Venigalla PM, Sharma R, Gupta SD, Makharia G, Sahni P, Ahuja V. Long-term outcomes of anti-tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease. JGH Open 2021;5:420-7. [PMID: 33860091 DOI: 10.1002/jgh3.12370] [Reference Citation Analysis]
47 Suarez-Lopez L, Kong YW, Sriram G, Patterson JC, Rosenberg S, Morandell S, Haigis KM, Yaffe MB. MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer. Front Immunol 2020;11:607891. [PMID: 33708191 DOI: 10.3389/fimmu.2020.607891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ahn CH, Kim SC. Two case reports: Colorectal adenocarcinoma in children. Medicine (Baltimore) 2017;96:e8074. [PMID: 29145239 DOI: 10.1097/MD.0000000000008074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
49 Corbera-Hincapie M, Beasley GL. A Challenging Treatment Decision for a Rare Association: Case Report of Familial Turcot Syndrome With Fistulizing Crohn's Disease. Front Pediatr 2018;6:83. [PMID: 29670872 DOI: 10.3389/fped.2018.00083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39 Suppl 1:19-31. [PMID: 30851228 DOI: 10.1111/liv.14095] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 34.7] [Reference Citation Analysis]
51 Ulugöl S, Hering L, Manzini R, Montalban Arques A, Gottier C, Lang S, Scharl M, Spalinger MR. Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23. Inflamm Intest Dis 2019;4:14-26. [PMID: 31172009 DOI: 10.1159/000499157] [Reference Citation Analysis]
52 Liu S, Zhu Y, Wu P, Xiong H. Highly Sensitive D-A-D-Type Near-Infrared Fluorescent Probe for Nitric Oxide Real-Time Imaging in Inflammatory Bowel Disease. Anal Chem 2021;93:4975-83. [PMID: 33691397 DOI: 10.1021/acs.analchem.1c00281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
53 Arima H, Motoyama K, Higashi T. Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs. Ther Deliv 2017;8:215-32. [PMID: 28222660 DOI: 10.4155/tde-2016-0064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
54 Machackova T, Vychytilova-Faltejskova P, Souckova K, Trachtova K, Brchnelova D, Svoboda M, Kiss I, Prochazka V, Kala Z, Slaby O. MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion. Cancers (Basel) 2020;12:E3518. [PMID: 33255928 DOI: 10.3390/cancers12123518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 Li Y, Zhang N, Ma C, Xu W, Jin G, Zheng Y, Zhang L, Liu B, Gao C, Liu S. The overexpression of Tipe2 in CRC cells suppresses survival while endogenous Tipe2 accelerates AOM/DSS induced-tumor initiation. Cell Death Dis 2021;12:1001. [PMID: 34702807 DOI: 10.1038/s41419-021-04289-0] [Reference Citation Analysis]
56 Feng JH, Navas CM, Olofson AM, Ahmed N. Signet-Ring Cell Carcinoma Presenting as Hematochezia in a Patient with Crohn's Disease. Case Rep Gastroenterol 2019;13:85-8. [PMID: 31043934 DOI: 10.1159/000493920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Rapa SF, Di Paola R, Cordaro M, Siracusa R, D'Amico R, Fusco R, Autore G, Cuzzocrea S, Stuppner H, Marzocco S. Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis. Biomedicines 2021;9:67. [PMID: 33445622 DOI: 10.3390/biomedicines9010067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Hwang D, Jo H, Kim J, Lim Y. Oxyresveratrol-containing Ramulus mori ethanol extract attenuates acute colitis by suppressing inflammation and increasing mucin secretion. Journal of Functional Foods 2017;35:146-58. [DOI: 10.1016/j.jff.2017.05.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
59 Mi C, Guan M, Zhang X, Yang L, Wu S, Yang Z, Guo Z, Liao J, Zhou J, Lin F, Ma E, Jin D, Yuan X. High Spatial and Temporal Resolution NIR-IIb Gastrointestinal Imaging in Mice. Nano Lett 2022. [PMID: 35324206 DOI: 10.1021/acs.nanolett.1c04909] [Reference Citation Analysis]
60 Weingarden AR, Rubin SJS, Gubatan J. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(8): 772-798 [PMID: 34457186 DOI: 10.4251/wjgo.v13.i8.772] [Reference Citation Analysis]
61 Sun X, Cai Y, Fleming C, Tong Z, Wang Z, Ding C, Qu M, Zhang HG, Suo J, Yan J. Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells. Oncoimmunology 2017;6:e1313369. [PMID: 28638741 DOI: 10.1080/2162402X.2017.1313369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
62 Zhang K, Kong X, Li Y, Wang Z, Zhang L, Xuan L. PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases. Front Pharmacol 2022;13:854967. [DOI: 10.3389/fphar.2022.854967] [Reference Citation Analysis]
63 Brown E, Taylor CT. Hypoxia-sensitive pathways in intestinal inflammation. J Physiol 2018;596:2985-9. [PMID: 29114885 DOI: 10.1113/JP274350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
64 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
65 Zakrzewski M, Wilkins SJ, Helman SL, Brilli E, Tarantino G, Anderson GJ, Frazer DM. Supplementation with Sucrosomial® iron leads to favourable changes in the intestinal microbiome when compared to ferrous sulfate in mice. Biometals 2021. [PMID: 34697758 DOI: 10.1007/s10534-021-00348-3] [Reference Citation Analysis]
66 Sipos F, Firneisz G, Műzes G. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases. World J Gastroenterol 2016;22:7938-50. [PMID: 27672289 DOI: 10.3748/wjg.v22.i35.7938] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
67 Kim MJ, Hong SN, Kim YH, Choe YH. [How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?]. Korean J Gastroenterol 2021;77:227-30. [PMID: 34035200 DOI: 10.4166/kjg.2021.065] [Reference Citation Analysis]
68 Mota JF, Walter J, Prado CM. Insights Into the Relationship Between Gut Microbiota and Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:251-65. [DOI: 10.1007/s11888-018-0419-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Tummala P, Rooke M, Dahlstrom JE, Takahashi S, Casarotto MG, Fernando N, Hughes MM, O'Neill LAJ, Board PG. Glutathione transferase Omega 1 confers protection against azoxymethane-induced colorectal tumour formation. Carcinogenesis 2021;42:853-63. [PMID: 33564842 DOI: 10.1093/carcin/bgab008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Dharmawansa KVS, Hoskin DW, Rupasinghe HPV. Chemopreventive Effect of Dietary Anthocyanins against Gastrointestinal Cancers: A Review of Recent Advances and Perspectives. Int J Mol Sci 2020;21:E6555. [PMID: 32911639 DOI: 10.3390/ijms21186555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
71 Tamang N, Ramamoorthy G, Joshi M, Choudury AR, B. SK, Golakoti NR, Doble M. Diarylidenecyclopentanone derivatives as potent anti-inflammatory and anticancer agents. Med Chem Res 2020;29:1579-89. [DOI: 10.1007/s00044-020-02578-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. Stem Cells Int 2020;2020:7819824. [PMID: 32256612 DOI: 10.1155/2020/7819824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
73 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
74 Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era. Therap Adv Gastroenterol 2020;13:1756284820920779. [PMID: 32523622 DOI: 10.1177/1756284820920779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kramer CD, Genco CA. Microbiota, Immune Subversion, and Chronic Inflammation. Front Immunol. 2017;8:255. [PMID: 28348558 DOI: 10.3389/fimmu.2017.00255] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
76 Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based Survey. Inflamm Bowel Dis 2020;26:1445-50. [PMID: 32100018 DOI: 10.1093/ibd/izaa032] [Reference Citation Analysis]
77 Ronchetti S, Gentili M, Ricci E, Migliorati G, Riccardi C. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:1017-25. [PMID: 31961437 DOI: 10.1093/ibd/izz331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
78 Lee SY, Lee DY, Kang JH, Kim JH, Jeong JW, Kim HW, Oh DH, Yoon SH, Hur SJ. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention. Food Research International 2022;156:111327. [DOI: 10.1016/j.foodres.2022.111327] [Reference Citation Analysis]
79 Carvalho L, Gomes JRM, Tavares LC, Xavier AR, Klika KD, Holmdahl R, Carvalho RA, Souto-Carneiro MM. Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:701. [PMID: 29867918 DOI: 10.3389/fimmu.2018.00701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
81 Rocha J, Direito R, Lima A, Mota J, Gonçalves M, Duarte MP, Solas J, Peniche BF, Fernandes A, Pinto R, Ferreira RB, Sepodes B, Figueira ME. Reduction of inflammation and colon injury by a Pennyroyal phenolic extract in experimental inflammatory bowel disease in mice. Biomed Pharmacother 2019;118:109351. [PMID: 31545244 DOI: 10.1016/j.biopha.2019.109351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Chin YH, Jain SR, Lee MH, Ng CH, Lin SY, Mai AS, Muthiah MD, Foo FJ, Sundar R, Ong DEH, Leow WQ, Leong R, Chan WPW. Small bowel adenocarcinoma in Crohn's disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes. Int J Colorectal Dis 2021. [PMID: 34704127 DOI: 10.1007/s00384-021-04050-1] [Reference Citation Analysis]
83 Choe EK, Lee S, Kim SY, Shivakumar M, Park KJ, Chai YJ, Kim D. Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer-Integrative Analysis of TCGA Data. Cancers (Basel) 2021;13:751. [PMID: 33670198 DOI: 10.3390/cancers13040751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Hyder A. RETRACTED: Dietary oligosaccharides attenuate DSS-induced colitis in mice, induce PGlyRP3 expression, and inhibit NF-κB and MEK/ERK signaling. Cell Immunol 2020;354:104144. [PMID: 32619849 DOI: 10.1016/j.cellimm.2020.104144] [Reference Citation Analysis]
85 Liu Y, Yang X, Wang Y, Yang Y, Sun D, Li H, Chen L. Targeting SHP2 as a therapeutic strategy for inflammatory diseases. Eur J Med Chem 2021;214:113264. [PMID: 33582386 DOI: 10.1016/j.ejmech.2021.113264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Liu H, Cui B, Zhang Z. Mechanism of glycometabolism regulation by bioactive compounds from the fruits of Lycium barbarum: A review. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111408] [Reference Citation Analysis]
87 Rocha R, de J Santos G, Santana G. Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2021; 12(5): 90-99 [PMID: 34616585 DOI: 10.4292/wjgpt.v12.i5.90] [Reference Citation Analysis]
88 Abdelmegid AM, Abdo FK, Ahmed FE, Kattaia AAA. Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression. Sci Rep 2019;9:10176. [PMID: 31308463 DOI: 10.1038/s41598-019-46671-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
89 Svrcek M, Borralho Nunes P, Villanacci V, Beaugerie L, Rogler G, De Hertogh G, Tripathi M, Feakins R; H-ECCO group. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation. J Crohns Colitis 2018;12:1486-98. [PMID: 30202940 DOI: 10.1093/ecco-jcc/jjy132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
90 Zhu Z, Mei Z, Guo Y, Wang G, Wu T, Cui X, Huang Z, Zhu Y, Wen D, Song J, He H, Xu W, Cui L, Liu C. Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis. J Crohns Colitis. 2018;12:546-558. [PMID: 29370346 DOI: 10.1093/ecco-jcc/jjy006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
91 Niedert EE, Bi C, Adam G, Lambert E, Solorio L, Goergen CJ, Cappelleri DJ. A Tumbling Magnetic Microrobot System for Biomedical Applications. Micromachines (Basel) 2020;11:E861. [PMID: 32957563 DOI: 10.3390/mi11090861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
92 Gamah M, Alahdal M, Zhang Y, Zhou Y, Ji Q, Yuan Z, Han Y, Shen X, Ren Y, Zhang W. High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes. Bioengineered 2021;12:7985-94. [PMID: 34666625 DOI: 10.1080/21655979.2021.1975017] [Reference Citation Analysis]
93 Girardi B, Principi M, Pricci M, Giorgio F, Iannone A, Losurdo G, Ierardi E, Di Leo A, Barone M. Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model. Carcinogenesis. 2018;39:1274-1282. [PMID: 30084990 DOI: 10.1093/carcin/bgy104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
94 Liu C, Cui Y, Pi F, Cheng Y, Guo Y, Qian H. Extraction, Purification, Structural Characteristics, Biological Activities and Pharmacological Applications of Acemannan, a Polysaccharide from Aloe vera: A Review. Molecules 2019;24:E1554. [PMID: 31010204 DOI: 10.3390/molecules24081554] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
95 Curtis JR, Regueiro M, Yun H, Su C, DiBonaventura M, Lawendy N, Nduaka CI, Koram N, Cappelleri JC, Chan G, Modesto I, Lichtenstein GR. Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data. Inflamm Bowel Dis 2021;27:1394-408. [PMID: 33324993 DOI: 10.1093/ibd/izaa289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984 [DOI: 10.12998/wjcc.v10.i3.966] [Reference Citation Analysis]
97 Bandaru SSM, Bhilare S, Cardozo J, Chrysochos N, Schulzke C, Sanghvi YS, Gunturu KC, Kapdi AR. Pd/PTABS: Low-Temperature Thioetherification of Chloro(hetero)arenes. J Org Chem 2019;84:8921-40. [DOI: 10.1021/acs.joc.9b00840] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
98 Motavallian A, Zamani E, Bouzari S, Rezaeyan F, Karimian P, Evazalipour M. Anti-inflammatory effect of pregabalin on acetic acid-induced colitis in the rats. Res Pharm Sci 2022;17:35-42. [PMID: 34909042 DOI: 10.4103/1735-5362.329924] [Reference Citation Analysis]
99 Lavelle J, Storan D, Eswara Murthy V, De Dominicis N, Mulcahy HE, Mchugh L. Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies. JCM 2022;11:2757. [DOI: 10.3390/jcm11102757] [Reference Citation Analysis]
100 Noda M, Danshiitsoodol N, Kanno K, Uchida T, Sugiyama M. The Exopolysaccharide Produced by Lactobacillus paracasei IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS-Induced Ulcerative Colitis. Microorganisms 2021;9:2243. [PMID: 34835369 DOI: 10.3390/microorganisms9112243] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Wang G, Yuan J, Cai X, Xu Z, Wang J, Ocansey DKW, Yan Y, Qian H, Zhang X, Xu W, Mao F. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med 2020;10:e113. [PMID: 32564521 DOI: 10.1002/ctm2.113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
102 Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Mottaghi-Moghaddam A, Ghazaghi A, Ghandehari M, Alizade-Noghani M, Khazaei M, Ghayour-Mobarhan M, Ferns GA, Parizadeh SMR, Avan A. Vitamin D in inflammatory bowel disease: From biology to clinical implications. Complement Ther Med 2019;47:102189. [PMID: 31779998 DOI: 10.1016/j.ctim.2019.08.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
103 Kubatka P, Mazurakova A, Samec M, Koklesova L, Zhai K, Al-ishaq R, Kajo K, Biringer K, Vybohova D, Brockmueller A, Pec M, Shakibaei M, Giordano FA, Büsselberg D, Golubnitschaja O. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways. EPMA Journal 2021;12:559-87. [DOI: 10.1007/s13167-021-00257-y] [Reference Citation Analysis]
104 Rademakers G, Vaes N, Schonkeren S, Koch A, Sharkey KA, Melotte V. The role of enteric neurons in the development and progression of colorectal cancer. Biochim Biophys Acta Rev Cancer 2017;1868:420-34. [PMID: 28847715 DOI: 10.1016/j.bbcan.2017.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
105 Forés-Martos J, Catalá-López F, Sánchez-Valle J, Ibáñez K, Tejero H, Palma-Gudiel H, Climent J, Pancaldi V, Fañanás L, Arango C, Parellada M, Baudot A, Vogt D, Rubenstein JL, Valencia A, Tabarés-Seisdedos R. Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer. Mol Autism 2019;10:17. [PMID: 31007884 DOI: 10.1186/s13229-019-0262-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
106 Weimers P, Ankersen DV, Løkkegaard ECL, Burisch J, Munkholm P. Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015. Inflamm Bowel Dis 2021:izaa340. [PMID: 33409534 DOI: 10.1093/ibd/izaa340] [Reference Citation Analysis]
107 Noto CN, Hoft SG, DiPaolo RJ. Mast Cells as Important Regulators in Autoimmunity and Cancer Development. Front Cell Dev Biol 2021;9:752350. [PMID: 34712668 DOI: 10.3389/fcell.2021.752350] [Reference Citation Analysis]
108 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2022;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
109 Peixoto RD, Ferreira AR, Cleary JM, Fogacci JP, Vasconcelos JP, Jácome AA. Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy. J Gastrointest Cancer 2022. [PMID: 35288863 DOI: 10.1007/s12029-022-00816-0] [Reference Citation Analysis]
110 Isidori M, Corbee RJ, Trabalza-marinucci M. Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy—A Narrative Review. Veterinary Sciences 2022;9:37. [DOI: 10.3390/vetsci9020037] [Reference Citation Analysis]
111 Ma R, Yuan D, Guo Y, Yan R, Li K. Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Front Immunol 2020;11:1600. [PMID: 33013819 DOI: 10.3389/fimmu.2020.01600] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Wu S, Xie S, Yuan C, Yang Z, Liu S, Zhang Q, Sun F, Wu J, Zhan S, Zhu S, Zhang S. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank. Inflamm Bowel Dis 2022:izac096. [PMID: 35639937 DOI: 10.1093/ibd/izac096] [Reference Citation Analysis]
113 Su D, Zhang D, Jin J, Ying L, Han M, Chen K, Li B, Wu J, Xie Z, Zhang F, Lin Y, Cheng G, Li JY, Huang M, Wang J, Wang K, Zhang J, Li F, Xiong L, Futreal A, Mao W. Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma. Nat Commun 2019;10:5076. [PMID: 31700061 DOI: 10.1038/s41467-019-12846-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
114 May S, Mcdermott G, Marchesi JR, Parry L, Wang L. Impact of black raspberries on the normal and malignant Apc deficient murine gut microbiome. JBR 2020;10:61-76. [DOI: 10.3233/jbr-180372] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
115 Moreno LO, Fernández-tomé S, Abalo R. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021;1:189-210. [DOI: 10.3390/biologics1020012] [Reference Citation Analysis]
116 Andersson D, Kristiansson H, Kubista M, Ståhlberg A. Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations. Expert Rev Mol Diagn 2021;21:299-310. [PMID: 33683971 DOI: 10.1080/14737159.2021.1889371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Barteneva NS, Baiken Y, Fasler-kan E, Alibek K, Wang S, Maltsev N, Ponomarev ED, Sautbayeva Z, Kauanova S, Moore A, Beglinger C, Vorobjev IA. Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017;1868:372-93. [DOI: 10.1016/j.bbcan.2017.06.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
118 Levy A, Borren NZ, Maxner B, Tan W, Bellavance D, Staller K, Chung D, Khalili H, Ananthakrishnan AN. Cancer risk in microscopic colitis: a retrospective cohort study. BMC Gastroenterol 2019;19:1. [PMID: 30611218 DOI: 10.1186/s12876-018-0926-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
119 Guan Q, Zeng Q, Jiang W, Xie J, Cheng J, Yan H, He J, Xu Y, Guan G, Guo Z, Ao L. A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions. Front Genet 2020;11:573787. [PMID: 33519891 DOI: 10.3389/fgene.2020.573787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 El-Akabawy G, El-Sherif NM. Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress. Biomed Pharmacother 2019;111:841-51. [PMID: 30616083 DOI: 10.1016/j.biopha.2019.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
121 Rehman NU, Ansari MN, Palla AH, Karim A, Imam F, Raish M, Hamad AM, Noman M. Myrica salicifolia Hochst. ex A. Rich. suppress acetic acid-induced ulcerative colitis in rats by reducing TNF-alpha and interleukin-6, oxidative stress parameters and improving mucosal protection. Hum Exp Toxicol 2022;41:9603271221102518. [PMID: 35561078 DOI: 10.1177/09603271221102518] [Reference Citation Analysis]
122 Tian R, Liu X, Luo Y, Jiang S, Liu H, You F, Zheng C, Wu J. Apoptosis Exerts a Vital Role in the Treatment of Colitis-Associated Cancer by Herbal Medicine. Front Pharmacol 2020;11:438. [PMID: 32410986 DOI: 10.3389/fphar.2020.00438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zhou Y, Dou F, Song H, Liu T. Anti‐ulcerative effects of wogonin on ulcerative colitis induced by dextran sulfate sodium via Nrf2/ TLR4 / NF‐κB signaling pathway in BALB /c mice. Environmental Toxicology. [DOI: 10.1002/tox.23457] [Reference Citation Analysis]
124 Kirby C, Baig A, Avlasevich SL, Torous DK, Tian S, Singh P, Bemis JC, Saubermann LJ, Dertinger SD. Dextran sulfate sodium mouse model of inflammatory bowel disease evaluated for systemic genotoxicity via blood micronucleus and Pig-a gene mutation assays. Mutagenesis 2020;35:161-7. [PMID: 32050029 DOI: 10.1093/mutage/geaa006] [Reference Citation Analysis]
125 Kulminski AM, Loiko E, Loika Y, Culminskaya I. Pleiotropic predisposition to Alzheimer's disease and educational attainment: insights from the summary statistics analysis. Geroscience 2021. [PMID: 34743297 DOI: 10.1007/s11357-021-00484-1] [Reference Citation Analysis]
126 Qiu X, Ma J, Wang K, Zhang H. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget. 2017;8:1031-1045. [PMID: 27906680 DOI: 10.18632/oncotarget.13715] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
127 Silveira ALM, Ferreira AVM, Teixeira MM. High-Fiber Diets in Gastrointestinal Tract Diseases. Dietary Interventions in Gastrointestinal Diseases. Elsevier; 2019. pp. 229-44. [DOI: 10.1016/b978-0-12-814468-8.00019-3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Im SA, Kim JW, Kim HS, Park CS, Shin E, Do SG, Park YI, Lee CK. Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel. Int Immunopharmacol 2016;40:428-35. [PMID: 27697726 DOI: 10.1016/j.intimp.2016.09.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
129 Valencia JC, Egbukichi N, Erwin-Cohen RA. Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity. J Interferon Cytokine Res 2019;39:72-84. [PMID: 30562133 DOI: 10.1089/jir.2018.0060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
130 Bourayou E, Golub R. Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma. Front Immunol 2022;13:846923. [PMID: 35281021 DOI: 10.3389/fimmu.2022.846923] [Reference Citation Analysis]
131 Pérez-Pérez M, Pérez-Rodríguez G, Fdez-Riverola F, Lourenço A. Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics. J Med Internet Res 2019;21:e12610. [PMID: 31411142 DOI: 10.2196/12610] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
132 Axelrad JE, Sachs MC, Ludvigsson JF, Olén O; SWIBREG Study Group. A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data. Clin Epidemiol 2020;12:1059-72. [PMID: 33116900 DOI: 10.2147/CLEP.S265404] [Reference Citation Analysis]
133 Reinisch W, Sandborn WJ, Danese S, Hébuterne X, Kłopocka M, Tarabar D, Vaňásek T, Greguš M, Hellstern PA, Kim JS, Sparrow MP, Gorelick KJ, Hoy M, Goetsch M, Bliss C, Gupta C, Cataldi F, Vermeire S. Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II. J Crohns Colitis 2021;15:938-49. [PMID: 33599720 DOI: 10.1093/ecco-jcc/jjab023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
134 Al-Hariri M, Alsunni A, Shaikh MH, Gamal Eldin T, Al Ghamdi K, Alharbi AF, Alhawaj H, Chathoth S. Caffeic Acid Phenethyl Ester reduces Pro Inflammatory Cytokines in Moderate Swimming Test in Growing Rats Model. J Inflamm Res 2021;14:5653-7. [PMID: 34754212 DOI: 10.2147/JIR.S338973] [Reference Citation Analysis]
135 Lim JS, Oh J, Byeon S, Lee JS, Kim J. Protective Effect of Dioscorea batatas Peel Extract Against Intestinal Inflammation. Journal of Medicinal Food 2018;21:1204-17. [DOI: 10.1089/jmf.2018.4187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Lim JS, Hahn D, Gu MJ, Oh J, Lee JS, Kim J. Anti-inflammatory and antioxidant effects of 2, 7-dihydroxy-4, 6-dimethoxy phenanthrene isolated from Dioscorea batatas Decne. Appl Biol Chem 2019;62. [DOI: 10.1186/s13765-019-0436-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
137 Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases. Cells 2019;8:E1573. [PMID: 31817238 DOI: 10.3390/cells8121573] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
138 Roudsari NM, Lashgari NA, Zandi N, Pazoki B, Momtaz S, Sahebkar A, Abdolghaffari AH. PPARγ: A turning point for irritable bowel syndrome treatment. Life Sci 2020;257:118103. [PMID: 32681913 DOI: 10.1016/j.lfs.2020.118103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 2020;33:485-94. [PMID: 32879595 DOI: 10.20524/aog.2020.0507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Goswami AB, Karadarević D, Castaño-Rodríguez N. Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis. Inflamm Res 2022. [PMID: 35699756 DOI: 10.1007/s00011-022-01595-x] [Reference Citation Analysis]
141 Mirza-Aghazadeh-Attari M, Mohammadzadeh A, Mostavafi S, Mihanfar A, Ghazizadeh S, Sadighparvar S, Gholamzadeh S, Majidinia M, Yousefi B. Melatonin: An important anticancer agent in colorectal cancer. J Cell Physiol 2020;235:804-17. [PMID: 31276205 DOI: 10.1002/jcp.29049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
142 Pan DC, Krishnan V, Salinas AK, Kim J, Sun T, Ravid S, Peng K, Wu D, Nurunnabi M, Nelson JA, Niziolek Z, Guo J, Mitragotri S. Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer. Bioeng Transl Med 2021;6:e10166. [PMID: 33532580 DOI: 10.1002/btm2.10166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Fredericks E, Dealtry G, Roux S. β-Catenin Regulation in Sporadic Colorectal Carcinogenesis: Not as Simple as APC. Can J Gastroenterol Hepatol 2018;2018:4379673. [PMID: 30186819 DOI: 10.1155/2018/4379673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
144 Bhattarai A, Kowalczyk W, Tran TN. A literature review on large intestinal hyperelastic constitutive modeling. Clin Biomech (Bristol, Avon) 2021;88:105445. [PMID: 34416632 DOI: 10.1016/j.clinbiomech.2021.105445] [Reference Citation Analysis]
145 Vetter LE, Merkel S, Bénard A, Krautz C, Brunner M, Mittelstädt A, Schlegel N, Wiegering A, Germer CT, Weber K, Grützmann R, Weber GF. Colorectal cancer in Crohn's colitis is associated with advanced tumor invasion and a poorer survival compared with ulcerative colitis: a retrospective dual-center study. Int J Colorectal Dis 2021;36:141-50. [PMID: 32918621 DOI: 10.1007/s00384-020-03726-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Reyes ME, de La Fuente M, Hermoso M, Ili CG, Brebi P. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer. Front Immunol 2020;11:901. [PMID: 32499779 DOI: 10.3389/fimmu.2020.00901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
147 Chen G, Xie J, Liang T, Wang Y, Liao W, Song L, Zhang X. Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization. Acta Otolaryngol 2022;142:191-6. [PMID: 35195051 DOI: 10.1080/00016489.2022.2035431] [Reference Citation Analysis]
148 Branchi V, Weismüller TJ, Zhou T, Henn J, Semaan A, Glowka TR, Gonzalez-Carmona M, Strassburg C, Kalff JC, Manekeller S, Matthaei H. [Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients]. Chirurg 2021;92:148-57. [PMID: 32488382 DOI: 10.1007/s00104-020-01197-5] [Reference Citation Analysis]
149 Shapira S, Aiger G, Ohayon A, Kazanov D, Mdah F, Shimon MB, Hay-Levy M, Banon L, Laskov I, Mashiah J, Lev-Ari S, Arber N. Predictors of the CD24/CD11b Biomarker among Healthy Subjects. J Pers Med 2021;11:939. [PMID: 34575716 DOI: 10.3390/jpm11090939] [Reference Citation Analysis]
150 Abad C, Tan YV. Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice. J Mol Neurosci 2018;66:102-13. [PMID: 30105629 DOI: 10.1007/s12031-018-1150-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
151 Honan AM, Chen Z. Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support. Front Cell Dev Biol 2021;9:658984. [PMID: 34113615 DOI: 10.3389/fcell.2021.658984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Efferth T, Volm M. Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers. Arch Toxicol 2017;91:2515-38. [DOI: 10.1007/s00204-017-1938-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
153 Faye AS, Axelrad JE. Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes. Aliment Pharmacol Ther 2022;55:1459-60. [PMID: 35538352 DOI: 10.1111/apt.16936] [Reference Citation Analysis]
154 Tandra N, Wu P, Hu X, Mao F, Xu W, Qian H. Extracellular Vesicles: A New Nano Tool for the Treatment of Inflammatory Bowel Diseases. CNANO 2019;15:589-95. [DOI: 10.2174/1573413715666190411141126] [Reference Citation Analysis]
155 Ohnishi S, Hiramoto K, Ma N, Kawanishi S. Chemoprevention by aspirin against inflammation-related colorectal cancer in mice. J Clin Biochem Nutr 2021;69:265-71. [PMID: 34857988 DOI: 10.3164/jcbn.20-189] [Reference Citation Analysis]
156 Nehme F, Schneider A, Hamid F. Appendiceal Adenocarcinoma Associated With Ulcerative Colitis. ACG Case Rep J 2019;6:e00255. [PMID: 32309470 DOI: 10.14309/crj.0000000000000255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Kaeid Sharaf L, Shukla G. Probiotics (Lactobacillus acidophilus and Lactobacillus rhamnosus GG) in Conjunction with Celecoxib (selective COX-2 inhibitor) Modulated DMH-Induced Early Experimental Colon Carcinogenesis. Nutr Cancer 2018;70:946-55. [PMID: 30183370 DOI: 10.1080/01635581.2018.1490783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
158 Covaci O-, Samohvalov D, Manta C-, Buhalteanu L, Barbatu A, Baibarac M, Daescu M, Matea A, Gherca D. Novel anhydrous solid-state form of Azathioprine: The assessing of crystal structure by powder X-Ray diffraction, Infrared Absorption Spectroscopy and Raman scattering. Journal of Molecular Structure 2019;1178:702-10. [DOI: 10.1016/j.molstruc.2018.10.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
159 Dent M, Matoba N. Cancer biologics made in plants. Curr Opin Biotechnol 2020;61:82-8. [PMID: 31785553 DOI: 10.1016/j.copbio.2019.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
160 Ishak NIM, Mohamed S, Madzuki IN, Mustapha NM, Esa NM. Limonin modulated immune and inflammatory responses to suppress colorectal adenocarcinoma in mice model. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1907-15. [PMID: 34009457 DOI: 10.1007/s00210-021-02101-6] [Reference Citation Analysis]
161 Loomans-Kropp HA, Umar A. Cancer prevention and screening: the next step in the era of precision medicine. NPJ Precis Oncol 2019;3:3. [PMID: 30701196 DOI: 10.1038/s41698-018-0075-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
162 Zhou X, Peng M, He Y, Peng J, Zhang X, Wang C, Xia X, Song W. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment. Front Oncol 2021;11:619003. [PMID: 33767987 DOI: 10.3389/fonc.2021.619003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
163 Sun J, Jia H, Bao X, Wu Y, Zhu T, Li R, Zhao H. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer. Cell Death Dis. 2021;12:123. [PMID: 33495437 DOI: 10.1038/s41419-020-03376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
164 Phelan JP, Reen FJ, Caparros-Martin JA, O'Connor R, O'Gara F. Rethinking the bile acid/gut microbiome axis in cancer. Oncotarget 2017;8:115736-47. [PMID: 29383197 DOI: 10.18632/oncotarget.22803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
165 Molinaro C, Martoriati A, Cailliau K. Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies. Cancers (Basel) 2021;13:3819. [PMID: 34359720 DOI: 10.3390/cancers13153819] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Chen M, Yuan C, Xu T. An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2020;44:302-9. [PMID: 31447293 DOI: 10.1016/j.clinre.2019.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
167 Jacobs MN, Colacci A, Corvi R, Vaccari M, Aguila MC, Corvaro M, Delrue N, Desaulniers D, Ertych N, Jacobs A, Luijten M, Madia F, Nishikawa A, Ogawa K, Ohmori K, Paparella M, Sharma AK, Vasseur P. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 2020;94:2899-923. [PMID: 32594184 DOI: 10.1007/s00204-020-02784-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
168 Geng Z, Geng Q. Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis. Front Surg 2021;8:636791. [PMID: 34124132 DOI: 10.3389/fsurg.2021.636791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Tulumović E, Salkić N, Tulumović D. Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up. World J Gastroenterol 2021; 27(20): 2630-2642 [PMID: 34092980 DOI: 10.3748/wjg.v27.i20.2630] [Reference Citation Analysis]
170 Borzì AM, Biondi A, Basile F, Luca S, Vicari ESD, Vacante M. Olive Oil Effects on Colorectal Cancer. Nutrients 2018;11:E32. [PMID: 30583613 DOI: 10.3390/nu11010032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
171 Lin SC, Goldowsky A, Papamichael K, Cheifetz AS. The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy. Inflamm Bowel Dis 2019;25:998-1005. [PMID: 30590558 DOI: 10.1093/ibd/izy376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
172 Loft ND, Vaengebjerg S, Skov L. Cancer risk in patients with psoriasis: should we be paying more attention? Expert Review of Clinical Immunology 2020;16:479-92. [DOI: 10.1080/1744666x.2020.1754194] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
173 Deng XQ, Zhang HB, Wang GF, Xu D, Zhang WY, Wang QS, Cui YL. Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer. Int J Pharm 2019;570:118644. [PMID: 31465837 DOI: 10.1016/j.ijpharm.2019.118644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
174 Wang Z, Zhang H, Yang H, Zhang M, Qian J. The Incidence Rate and Risk Factors of Malignancy in Elderly-Onset Inflammatory Bowel Disease: A Chinese Cohort Study From 1998 to 2020. Front Oncol 2021;11:788980. [PMID: 34956904 DOI: 10.3389/fonc.2021.788980] [Reference Citation Analysis]
175 Kubiritova Z, Radvanszky J, Gardlik R. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E3662. [PMID: 31357438 DOI: 10.3390/ijms20153662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
176 Smrekar N, Drobne D, Smid LM, Ferkolj I, Stabuc B, Ihan A, Kopitar AN. Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease. Radiol Oncol 2018;52:443-52. [PMID: 30511938 DOI: 10.2478/raon-2018-0045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
177 Cheng J, Guo Y, Guan G, Huang H, Jiang F, He J, Wu J, Guo Z, Liu X, Ao L. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA. J Cell Mol Med 2021;25:3622-33. [PMID: 33719152 DOI: 10.1111/jcmm.16467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Taman H, Fenton CG, Hensel IV, Anderssen E, Florholmen J, Paulssen RH. Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis. J Crohns Colitis 2018;12:1338-47. [PMID: 30137272 DOI: 10.1093/ecco-jcc/jjy117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
179 Jakimovski D, Eckert SP, Zivadinov R, Weinstock-Guttman B. Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Rev Neurother 2021;21:353-64. [PMID: 33595379 DOI: 10.1080/14737175.2021.1886082] [Reference Citation Analysis]
180 Kirk PS, Govani S, Borza T, Hollenbeck BK, Davis J, Shumway D, Waljee AK, Skolarus TA. Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology 2017;104:131-6. [PMID: 28163082 DOI: 10.1016/j.urology.2017.01.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
181 Kobayashi T, Uda A, Udagawa E, Hibi T. Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis. J Crohns Colitis 2020;14:617-23. [PMID: 31867632 DOI: 10.1093/ecco-jcc/jjz204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
182 Davoodvandi A, Farshadi M, Zare N, Akhlagh SA, Alipour Nosrani E, Mahjoubin-Tehran M, Kangari P, Sharafi SM, Khan H, Aschner M, Baniebrahimi G, Mirzaei H. Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers. Front Pharmacol 2021;12:668567. [PMID: 34456716 DOI: 10.3389/fphar.2021.668567] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Uetake H, Yasuno M, Kawano T. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia. J Gastroenterol 2018;53:631-41. [PMID: 28884228 DOI: 10.1007/s00535-017-1387-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
184 Lo CH, Khalili H, Song M, Lochhead P, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:87-95.e4. [PMID: 32142939 DOI: 10.1016/j.cgh.2020.02.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
185 Frickenstein AN, Jones MA, Behkam B, McNally LR. Imaging Inflammation and Infection in the Gastrointestinal Tract. Int J Mol Sci 2019;21:E243. [PMID: 31905812 DOI: 10.3390/ijms21010243] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
186 Butrón-Bris B, Daudén E, Rodríguez-Jiménez P. Psoriasis Therapy and Skin Cancer: A Review. Life (Basel) 2021;11:1109. [PMID: 34685480 DOI: 10.3390/life11101109] [Reference Citation Analysis]
187 Mao F, Wu Y, Tang X, Wang J, Pan Z, Zhang P, Zhang B, Yan Y, Zhang X, Qian H, Xu W. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnol Lett 2017;39:929-38. [DOI: 10.1007/s10529-017-2315-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
188 Zha R, Ge E, Guo L, Gao Q, Lin Q, Zhou W, Jin X, Xie W, Yin H, Liu T. A newly identified polyunsaturated macamide alleviates dextran sulfate sodium-induced colitis in mice. Fitoterapia 2021;152:104916. [PMID: 33945874 DOI: 10.1016/j.fitote.2021.104916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Pastor-Anglada M, Urtasun N, Pérez-Torras S. Intestinal Nucleoside Transporters: Function, Expression, and Regulation. Compr Physiol 2018;8:1003-17. [PMID: 29978890 DOI: 10.1002/cphy.c170039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
190 Penate Medina T, Pan J, Damoah C, Humbert J, Köpnick A, Will O, Sebens S, Penate Medina O. Utilizing Sphingomyelinase Sensitizing Liposomes in Imaging Intestinal Inflammation in Dextran Sulfate Sodium-Induced Murine Colitis. Biomedicines 2022;10:413. [DOI: 10.3390/biomedicines10020413] [Reference Citation Analysis]
191 Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:872-880.e1. [PMID: 31302306 DOI: 10.1016/j.cgh.2019.06.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
192 Mollinedo F. Neutrophil Degranulation, Plasticity, and Cancer Metastasis. Trends Immunol 2019;40:228-42. [PMID: 30777721 DOI: 10.1016/j.it.2019.01.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 20.7] [Reference Citation Analysis]